Positive Results of Pediatric Dacryocystorhinostomy Enhanced by Intraoperative 5-Fluorouracil
Overview
This study evaluates the effectiveness of intraoperative nasal intramucosal 5-fluorouracil (5-FU) injections during external dacryocystorhinostomy (DCR) in pediatric patients with nasolacrimal duct obstruction (NLDO). The findings indicate a 100% success rate in preventing recurrence of epiphora in the studied cohort, with no postoperative complications reported.
Background
Pediatric nasolacrimal duct obstruction (NLDO) is a common condition that can lead to excessive tearing and potential complications such as dacryocystitis. Surgical intervention, particularly dacryocystorhinostomy (DCR), is often necessary after less invasive treatments fail. The use of adjunctive therapies like 5-FU, as suggested by existing literature, may enhance surgical outcomes, especially in high-risk populations.
Data Highlights
Parameter
Value
Patients
16
Eyes
19
Success Rate of Epiphora Recurrence
100%
Patients with Craniofacial Syndromes
10 (53%)
Patients with Previous Failed Stents
8 (42%)
Post-operative Complications
None
Key Findings
Intraoperative 5-FU injection resulted in no recurrence of epiphora in the studied cohort.
53% of the eyes treated were in patients with craniofacial syndromes.
42% of patients had a history of one or two failed stents prior to DCR.
No postoperative complications were reported in the study.
Clinical Implications
The findings indicate that the use of intraoperative 5-FU may be relevant in preventing recurrence of epiphora in pediatric patients undergoing DCR, particularly in those with craniofacial abnormalities or previous surgical failures.
Conclusion
Intraoperative nasal intramucosal 5-FU injections appear to enhance the success of DCR in pediatric patients with NLDO, improving surgical outcomes without complications.
